Combo-Med, Testosterone Mix, 400 mg/ml, 10 ml

This synergistic dual-component parenteral formulation by Bioniche Pharma combines two long-acting esterified compounds: Nandrolone Decanoate and Testosterone Cypionate. Engineered by Bioniche Pharma to supply complementary anabolic, erythropoietic, and androgenic support, it addresses systemic hormone deficiencies, promotes cellular nitrogen retention, and counteracts catabolic muscle depletion when paired with adequate dietary protein and calorie intake.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

Anabolic-androgenic compounds drive cellular protein synthesis, improve systemic nitrogen balance, and encourage tissue development across skeletal, muscular, and bone structures. Bioniche Pharma's dual-action formulation supports endogenous androgenic functions, including the maintenance of secondary male sexual characteristics. Systemically, this combination by Bioniche Pharma enhances cellular nitrogen conservation, promotes renal reabsorption of sodium, potassium, and phosphorus, decreases urinary calcium loss, and stimulates baseline protein synthesis.

INDICATIONS & CLINICAL USE

• Targeted therapeutic support for tissue repair, cellular regeneration, and physical restoration in undernourished, debilitated, or compromised patients using Bioniche Pharma formulations.
• Adjunctive management of severe catabolic wasting, cachexia, and muscle atrophy associated with chronic systemic diseases under clinical oversight.
• Hormone replacement therapy in severe male androgen deficiency requiring concomitant anabolic tissue support.

CONTRAINDICATIONS

• Male patients with confirmed or suspected carcinoma of the prostate gland or male breast cancer.
• Female breast carcinoma complicated by severe hypercalcemia (elevated serum calcium levels).
• Patients presenting with severe kidney failure, advanced renal impairment, or major hepatic dysfunction.
• Pregnancy and lactation owing to significant risks of fetal virilization, developmental toxicity, and systemic endocrine disruption.
• Known hypersensitivity or allergic response to Nandrolone Decanoate, Testosterone Cypionate, carrier oils, or compounding excipients in Bioniche Pharma injectables.

PRECAUTIONS & METABOLIC MONITORS

• Glycemic Monitoring: Anabolic-androgenic agents can alter peripheral insulin sensitivity and glucose clearance. Diabetic patients receiving Bioniche Pharma dual-steroid therapy should monitor blood sugar levels regularly, as anti-diabetic medication dosages may require adjustment.
• Pediatric Caution & Bone Aging: Contraindicated in pediatric populations due to heightened sensitivity to androgenic effects, risk of premature epiphyseal plate closure, precocious puberty, and stunted adult height. Periodic bone age radiography is required if administered under specialized medical conditions.
• Fluid & Electrolyte Balance: Retention of sodium, chloride, potassium, and water can precipitate peripheral edema and blood pressure elevations, necessitating regular cardiovascular monitoring during Bioniche Pharma therapy.

ADVERSE REACTIONS

• Endocrine & Reproductive: Testicular suppression, altered testicle volume, oligospermia, erectile dysfunction, priapism (painful or persistent erections), development of gynecomastia, and deep suppression of the pituitary-gonadal axis.
• Dermatological & Androgenic: Heightened sebum production, severe acne vulgaris, accelerated androgenetic alopecia, and alterations in body hair growth patterns.
• Gastrointestinal & Systemic: Gastrointestinal distress, rapid weight gain secondary to fluid retention, peripheral swelling, dyspnea, headaches, mood instability, and sleep disturbances (insomnia) linked to Bioniche Pharma dual-component administration.

DOSAGE & ADMINISTRATION

This dual-component formulation by Bioniche Pharma is intended strictly for deep intramuscular injection. To ensure stable circulating hormone levels, administration is generally scheduled twice weekly:

• Therapeutic Dosage: Standard administration ranges from 400 mg to 800 mg per week (1 ml to 2 ml total weekly volume) of Bioniche Pharma dual blend, precisely titrated based on diagnostic lab values, clinical indication, and physician oversight.
• Usage Restriction: Strictly contraindicated for pediatric use, adolescents, and female patients due to virilization risks.

STORAGE & HANDLING

Store Bioniche Pharma injectable products in a dry, cool location shielded from direct sunlight exposure and elevated heat. Do not refrigerate or freeze. Store strictly out of the reach and sight of children.